ACS Journal Cancer

12.5K posts

ACS Journal Cancer

@JournalCancer

An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)

Atlanta, Georgia, USA Katılım Ocak 2009

4.4K Takip Edilen31.4K Takipçiler

Sabitlenmiş Tweet

ACS Journal Cancer@JournalCancer·1d

What advances are changing palliative & supportive care for patients with cancer? Drs. Ruth O'Regan, Carrie Sha, Andrew Epstein, & Yael Schenker discuss this year's top advances, remaining challenges, & what's next. 🎧: cancerspeak.podbean.com/e/top-advances… @OncoAlert @oreganruth #PallOnc

English

735

ACS Journal Cancer@JournalCancer·10h

Can telehealth expand access to high-quality palliative care? 🎙️ Drs. Carrie Sha & Yael Schenker discuss how telehealth is shaping cancer care, and what questions remain, in our latest #CancerSpeak episode. Listen here: cancerspeak.podbean.com/e/top-advances… @OncoAlert @MSKCancerCenter

English

433

ACS Journal Cancer@JournalCancer·10h

New cross-sectional study led by @AmericanCancer researcher Dr. Jordan Baeker Bispo reveals that past-year mammography screening was higher among civically engaged women in the United States. See more study findings: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert @ACSNews @ACSCAN #BCSM

English

369

ACS Journal Cancer retweetledi

CA: A Cancer Journal for Clinicians@CACancerJournal·1d

What does cancer survivorship research look like today? This virtual collection from the @AmericanCancer Journals features the latest statistics and research articles on patient needs, long-term outcomes, and more. 🔗 acsjournals.onlinelibrary.wiley.com/doi/toc/10.332… @OncoAlert @JournalCancer

CA: A Cancer Journal for Clinicians tweet media

English

479

ACS Journal Cancer@JournalCancer·4d

Featured in #CancerScope: @US_FDA has approved nivolumab plus chemotherapy for adults and adolescents with previously untreated advanced-stage classic Hodgkin lymphoma. Section Editor @AjayNookaMD explores the clinical implications: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert

English

520

ACS Journal Cancer@JournalCancer·4d

Novel findings from this study: 🧬 Identifying genes more often altered in osteosarcoma vs. other cancers 👧 MYC & CCND3 amplification more prevalent in childhood osteosarcoma 📊 Proven mutual exclusivity & co-occurrence w/ stat robustness acsjournals.onlinelibrary.wiley.com/doi/full/10.10… @OncoAlert

English

639

ACS Journal Cancer@JournalCancer·5d

Read the latest in #CancerScope: The EZH2 inhibitor tazemetostat has been voluntarily withdrawn from the market following safety concerns identified in a confirmatory trial. Learn more, with commentary from Section Editor @AjayNookaMD: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert

English

1.3K

ACS Journal Cancer@JournalCancer·5d

Is greater neighborhood socioeconomic deprivation associated with poorer neurocognitive function in women with early-stage breast cancer before adjuvant therapy? See a new study led by Amanda L. Gentry MPH & @UPittNursing colleagues: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert

English

584

ACS Journal Cancer@JournalCancer·5d

Hot off the press today 📣 This review examines the challenges in applying ctDNA to early breast cancer, spanning patient selection, sampling logistics, specimen handling, assay performance, and sources of assay failure. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert #BCSM

English

1.3K

ACS Journal Cancer@JournalCancer·5d

Thank you to our friends at @OncoAlert for highlighting the recent review article on maintenance therapy in gynecologic malignancies by Page C. Widick MD et al in this week's newsletter! 📰 Read the full review here: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

OncoAlert@OncoAlert

📢 The OncoAlert Newsletter | This Week's Edition Is Out 🔥July 2-9 REGISTER TO GET IT👉 buff.ly/X6N7qLU or buff.ly/4xd4naf ⭐ SPOTLIGHT TRIAL: Adjuvant Pembrolizumab + Belzutifan for Renal-Cell Carcinoma — does adding a HIF-2α inhibitor to adjuvant immunotherapy change the game for high-risk resected ccRCC? The phase 3 data are in, and the efficacy-toxicity trade-off is worth a close look. Also in this edition: 🧬 Casdatifan's durable HIF-2α-driven response in refractory metastatic RCC 🩺 APCCC 2025: consensus reached on just 19% of prostate cancer diagnostic questions 🫁 Do PPIs blunt durvalumab's efficacy after chemoradiotherapy in stage III NSCLC? 🎯 [177Lu]Lu-edotreotide outperforming everolimus in GEP-NETs (COMPETE trial) 🎗️ Trastuzumab rezetecan nearly quadruples PFS in HER2+ metastatic breast cancer ➕ 4 more studies spanning lung, GI, breast, gyn onc, and multiple myeloma Curated for oncology professionals, by oncology professionals. Read the full edition 👉 OncoAlert360.com #OncologyNews #RenalCellCarcinoma #KidneyCancer #NSCLC #BreastCancer #NeuroendocrineTumors #MultipleMyeloma #Oncology #ClinicalResearch #OncoAlert @OncoAlert @matteolambe @aftimosp @E_de_Azambuja @DrSGraff @ErikaHamilton9 @double_whammied @maryam_lustberg @raalbany @hoperugo @stolaney1 @LoiSher @JaniceTNBCmets @montypal @DrDanielHeng @apolo_andrea @DrChoueiri @PGrivasMDPhD @TiansterZhang @neerajaiims @amerseburger @sonpavde @drenriquegrande @tompowles1 @cdanicas @nataliagandur @realbowtiedoc @Onco_Cifu88 @scocmem @FernandoOnco @ElisaAgostinett @to_be_elizabeth @Erman_Akkus @MarioBalsaMD @DrMirallas @GIMedOnc @UOzkerim @DrRishabhOnco @PaulJiL @DaisukeKotani @DraMartinezLago @p_ciracimd @BenWestphalen @CentralParkWMD @graokane @amandaNizamMD @DrVilmaPBarcia

English

819

ACS Journal Cancer@JournalCancer·6d

Direct oral anticoagulants (DOACs) may reduce mortality in atrial fibrillation patients with cancer regardless of time-in-therapeutic-range (TiTR). Authors caution the use of DOACs in high-bleeding risk patients with good TiTR. @OncoAlert #CardioOncology acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

English

706

ACS Journal Cancer@JournalCancer·6d

New & available #OpenAccess | Real-world effectiveness of chemotherapy regimens after #immunotherapy in patients with advanced #melanoma in Spain: Results from the GEM1801 study acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert @CureMelanoma

English

762

ACS Journal Cancer@JournalCancer·6d

⚡Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Drs. Heidi Worth & Luciano Costa from @uabmedicine summarize recent progress & ongoing trials likely to shape the field in the years to come. @OncoAlert #MMSM

English

640

ACS Journal Cancer retweetledi

CA: A Cancer Journal for Clinicians@CACancerJournal·6d

🌍 New Global Cancer Stats from @AmericanCancer @IARCWHO show 20.6 million people were diagnosed with cancer and 9.8 million died from cancer worldwide in 2024. The global cancer burden is projected to rise 53% to 31.5M by 2050. acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca… @FreddieBray_ @OncoAlert

English

658

ACS Journal Cancer@JournalCancer·7 Tem

Most older adults with advanced cancer say maintaining quality of life is more important than extending survival. Yet cancer care doesn't always reflect those priorities. 📖 Read more in #CancerScope, featuring new research from JAMA Oncology: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert

English

644

ACS Journal Cancer@JournalCancer·7 Tem

New today ✨ This editorial by Jacopo Olivieri MD, PhD et al comments on the recent article by @GwynDaviesMD et al on secondary malignancies after bendamustine-rituximab in patients with indolent non-Hodgkin lymphoma. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert @pancho_daz

English

936

ACS Journal Cancer@JournalCancer·7 Tem

New review article by @harvardmed @DanaFarber @BIDMChealth discusses current maintenance therapy practices, emerging areas of research, and challenges in gynecologic malignancies. 🔗: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert #gyncsm

English

1.9K

ACS Journal Cancer@JournalCancer·7 Tem

New editorial by Erin Van Blarigan ScD (@UCSF_Epibiostat) & Justin Brown PhD (@AdventHealth) discusses how the ACES expert panel consensus statement helps fill a critical gap in exercise recommendations for older cancer survivors. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert #GeriOnc

English

701

ACS Journal Cancer@JournalCancer·3 Tem

Limited evidence exists regarding QOL losses experienced by informal cancer caregivers. #OpenAccess work led by @DHE_Deakin researchers investigates annual opportunity costs, projected informal care costs, and QALE gaps. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert

English

587

ACS Journal Cancer@JournalCancer·2 Tem

According to authors, the results of this study have important clinical implications for determining candidacy for active surveillance in patients with GG2–3 #ProstateCancer tumors. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @Adam_Weiner535 @OncoAlert

English

844

Keşfet

@OncoAlert @MSKCancerCenter @AmericanCancer @ACSNews @ACSCAN @US_FDA @AjayNookaMD @UPittNursing